ALSO NOTED: Thailand may bust cancer patents; Watson scores marketing rights from Depomed;

> Thailand is mulling patent-breaking compulsory licenses for three cancer drugs, including one from Novartis, one from Sanofi-Aventis, and one from Genentech. Report

> Depomed and Watson Pharmaceuticals expanded a marketing agreement to give Watson the right to promote the UTI drug ProQuin in the OB/GYN market. Report

> Cubist Pharmaceuticals got Health Canada's OK to market its Cubicin intravenous antibiotic for skin infections and certain gram-positive infections. Report

> Indian drug maker Cadila Pharmaceutical got the FDA's nod for its rheumatoid arthritis remedy hydroxychloroquine sulfate. Report

> Lupin will invest $10 million in a new steroid-manufacturing facility in Indore, India. Report

And Finally... Space-traveling microbes get better, stronger, faster--just what we need, right? Yes, say researchers who think subjecting germs to extreme conditions may lead to new therapies for cancer and infectious disease. Report